. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Clinical Trials, Phase III as TopicDopamine/metabolismDrug Evaluation, PreclinicalHumansHuntington Disease/drug therapyHuntington Disease/physiopathologyMovement Disorders/drug therapyMovement Disorders/etiologyPiperidines/adverse effectsPiperidines/pharmacologyPiperidines/therapeutic use
Substances: See more » PiperidinespridopidineDopamine
Year: 2010 PMID: 20357796 DOI: 10.1038/nrd3149
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN: 1474-1776 Impact factor: 84.694